Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;22(Suppl 4):10–19. doi: 10.1002/clc.4960221604

Prehospital thrombolysis: An idea whose time has come

Christopher P Cannon 1,✉, Assaad J Sayah 2, Ron M Walls 3
PMCID: PMC6656260  PMID: 10492849

Abstract

Aggressive reperfusion therapy for myocardial infarction (MI) characterized by acute ST‐segment elevation leads to improved patient outcome. Furthermore, use of thrombolytic therapy is highly time‐dependent: reperfusion therapy is beneficial within 12 h, but the earlier it is administered, the more beneficial it is. Thus, the focus of both prehospital and emergency department management of patients with acute MI is on rapid identification and treatment. There are many components to the time delays between the onset of symptoms of acute MI and the achievement of reperfusion in the occluded infarct‐related artery. Time delays occur with both the patient and the prehospital emergency medical system, although patient delays are more significant. This article focuses on the prehospital management of acute MI, including (1) the rationale for rapid reperfusion in patients with acute MI, (2) the factors related to time delays in patient presentation to the hospital, and (3) strategies for reducing time delays, both patient‐ and medical system‐based.

Keywords: prehospital, reperfusion, acute myocardial infarction, patient presentation delay

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

References

  • 1. Cannon CP, Antman EM, Walls R, Braunwald E: Time as an adjunctive agent to thrombolytic therapy. J Thromb Thrombolysis 1994; 1: 27–34 [DOI] [PubMed] [Google Scholar]
  • 2. Braunwald E: The open‐artery theory is alive and well—again. N Engl J Med 1993; 329: 1650–1652 [DOI] [PubMed] [Google Scholar]
  • 3. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB: The wave‐front phenomenon of ischemic cell death: 1. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977; 56: 786–794 [DOI] [PubMed] [Google Scholar]
  • 4. Rentrop KP, Blanke H, Karsch KR, Kreuzer H: Initial experience with transluminal recanalization of the recently occluded infarct‐related coronary artery in acute myocardial infarction: Comparison with conventionally treated patients. Clin Cardiol 1979; 2: 92–105 [DOI] [PubMed] [Google Scholar]
  • 5. Ganz W, Buchbinder N, Marcus H, Mondkar A, Maddahi J, Charuzi Y, O'Connor L, Shell W, Fishbein MC, Kass R, Miyamoto A, Swan HJC: Intracoronary thrombolysis in evolving myocardial infarction. Am Heart J 1981; 101: 4–13 [DOI] [PubMed] [Google Scholar]
  • 6. Stadius ML, Davis K, Maynard C, Ritchie JL, Kennedy JW: Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. Circulation 1986; 74: 701–711 [DOI] [PubMed] [Google Scholar]
  • 7. Dalen JE, Gore JM, Braunwald E, Borer J, Goldberg RJ, Passamani ER, Forman S, Knatterud G, and the TIMI Investigators : Six‐ and twelve‐month follow‐up of the Phase I Thrombolysis in Myocardial Infarction (TIMI) Trial. Am J Cardiol 1988; 62: 179–185 [DOI] [PubMed] [Google Scholar]
  • 8. Belenkie I, Thompson CR, Manyari DE, Knudtson ML, Duff HJ, Poon M‐C, Smith ER: Importance of effective, early and sustained reperfusion during acute myocardial infarction. Am J Cardiol 1989; 63: 912–916 [DOI] [PubMed] [Google Scholar]
  • 9. Flygenring BP, Sheehan FH, Kennedy JW, Dodge HT, Braunwald E: Does arterial patency 90 minutes following thrombolytic therapy predict 42 day survival? (abstr). J Am Coll Cardiol 1991; 17(suppl A):275A [Google Scholar]
  • 10. Karagounis L, Sorensen SG, Menlove RL, Moreno F, Anderson JL: Does Thrombolysis in Myocardial Infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM‐2 Study. J Am Coll Cardiol 1992; 19: 1–10 [DOI] [PubMed] [Google Scholar]
  • 11. Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL: TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction: Ventriculographic, enzymatic and electrocardiographic evidence from the TEAM‐3 Study. Circulation 1993; 87: 1829–1839 [DOI] [PubMed] [Google Scholar]
  • 12. Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, Palmeri ST, Davis V, Gibson CM, Poole WK, Braunwald E: Comparison of front‐loaded recombinant tissue‐type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol 1994; 24: 1602–1610 [DOI] [PubMed] [Google Scholar]
  • 13. Cannon CP, McCabe CH, Henry TD, Schweiger M, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL, Sharaf BL, Edwards SJ, Rogers WJ, Williams DO, Braunwald E: A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue‐type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 Trial. J Am Coll Cardiol 1994; 23: 993–1003 [DOI] [PubMed] [Google Scholar]
  • 14. Lincoff AM, Topol EJ, Califf RM, Sigmon KN, Lee KL, Ohman EM, Rosenschein U, Ellis SG: Significance of a coronary artery with Thrombolysis in Myocardial Infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] Trials). Am J Cardiol 1995; 75: 871–876 [DOI] [PubMed] [Google Scholar]
  • 15. The GUSTO Angiographic Investigators : The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615–1622 [DOI] [PubMed] [Google Scholar]
  • 16. Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM, Ross AM: Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: Importance of early and complete infarct artery reperfusion. Circulation 1995; 91: 1923–1928 [DOI] [PubMed] [Google Scholar]
  • 17. Cannon CP, Braunwald E: GUSTO, TIMI and the case for rapid reperfusion. Acta Cardiol 1994; 49: 1–8 [PubMed] [Google Scholar]
  • 18. TIMI Study Group : The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I findings. N Engl J Med 1985; 312: 932–936 [DOI] [PubMed] [Google Scholar]
  • 19. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) : Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397–401 [PubMed] [Google Scholar]
  • 20. Timm TC, Ross R, McKendall GR, Braunwald E, Williams DO, and the TIMI Investigators : Left ventricular function and early cardiac events as a function of time to treatment with t‐PA: A report from TIMI II (abstr). Circulation 1991; 84 (suppl): II–230 [Google Scholar]
  • 21. Topol EJ, Califf RM, Lee KL: More on the GUSTO trial. N Engl J Med 1994; 331: 277–278 (Published errata appear in N Engl J Med 1994;331:687, and 1994;331:1323) [DOI] [PubMed] [Google Scholar]
  • 22. Newby LK, Rutsch WR, Califf RM, Simoons ML, Aylward PE, Armstrong PW, Woodlief LH, Lee KL, Topol EJ, Van de Werf F: Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol 1996; 27: 1646–1655 [DOI] [PubMed] [Google Scholar]
  • 23. O'Keefe JH, Rutherford BD, McConahay DR, Ligon RW, Johnson WL, Giorgi LV, Crockett JE, McCallister BD, Conn RD, Gura GM, Good TH, Steinhaus DM, Bateman TM, Shimsham TM, Hartzler GO: Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989; 64: 1221–1230 [DOI] [PubMed] [Google Scholar]
  • 24. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, Eisenberg M: Prehospital‐initiated vs hospital‐initiated thrombolytic therapy: Myocardial Infarction Triage and Intervention Trial. J Am Med Assoc 1993; 270: 1211–1216 [PubMed] [Google Scholar]
  • 25. Weaver WD: Time to thrombolytic treatment: Factors affecting delay and influence on outcome. J Am Coll Cardiol 1995; 25: 3S–9S [DOI] [PubMed] [Google Scholar]
  • 26. Cannon CP: Time to treatment: A crucial factor in thrombolysis and primary angioplasty. J Thromb Thrombolysis 1996; 3: 249–256 [DOI] [PubMed] [Google Scholar]
  • 27. Hand M, Brown C, Horan M, Simons Morton D: The National Heart Attack Alert Program: Progress at 5 years in educating providers, patients and the public, and future directions. J Thromb Thrombolysis 1998; 6: 9–17 [DOI] [PubMed] [Google Scholar]
  • 28. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee : Patient/bystander recognition and action: Rapid identification and treatment of acute myocardial infarction. Bethesda, Md: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, 1995: 29–46 [Google Scholar]
  • 29. National Heart Attack Alert Program Coordinating Committee Working Group on Educational Strategies to Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction : Educational strategies to prevent prehospital delay in patients at high risk for acute myocardial infarction: A report by the National Heart Attack Alert Program. J Thromb Thrombolysis 1998; 6: 47–61 [DOI] [PubMed] [Google Scholar]
  • 30. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee : 9–1–1: Rapid identification and treatment of acute myocardial infarction. Am J Emerg Med 1995; 13: 188–195 [PubMed] [Google Scholar]
  • 31. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee : Staffing and equipping emergency medical services systems: Rapid identification and treatment of acute myocardial infarction. Am J Emerg Med 1995; 13: 58–65 [PubMed] [Google Scholar]
  • 32. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee : Emergency medical dispatching: Rapid identification and treatment of acute myocardial infarction. Am J Emerg Med 1995; 13: 67–73 [PubMed] [Google Scholar]
  • 33. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee : Access to timely and optimal care of patients with acute coronary syndromes—community planning considerations: A report by the National Heart Attack Alert Program. J Thromb Thrombolysis 1998; 6: 19–36 [DOI] [PubMed] [Google Scholar]
  • 34. Selker HP, Zalenski RJ, Antman EM, Aufderheide TP, Bernard SA, Bonow RO, Gibler WB, Hagen MD, Johnson P, Lau J, McNutt RA, Ornato J, Schwartz JS, Scott JD, Tunick PA, Weaver WD: An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: A report from a National Heart Attack Alert Working Group. Ann Emerg Med 1997; 29: 13–87 [DOI] [PubMed] [Google Scholar]
  • 35. National Heart Attack Alert Program Coordinating Committee—60 Minutes to Treatment Working Group : Emergency department: Rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med 1994; 23: 311–329 [PubMed] [Google Scholar]
  • 36. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, Rubison M, Tiefenbrunn AJ, Weaver WD: Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction. Circulation 1994; 90: 2103–2114 [DOI] [PubMed] [Google Scholar]
  • 37. Dracup K, Moser DK: Treatment‐seeking behavior among those with signs and symptoms of acute myocardial infarction. Heart Lung 1991; 20: 570–575 [PubMed] [Google Scholar]
  • 38. Ridker PM, Manson JE, Goldhaber SZ, Hennekens CH, Buring JE: Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction. Am J Cardiol 1992; 70: 10–13 [DOI] [PubMed] [Google Scholar]
  • 39. Cannon CP, Henry TD, Schweiger MJ, Haugland JM, McKendall GR, Shah PK, Gleason R, McCabe CH, Antman EA, Braunwald E: Current management of ST elevation myocardial infarction and outcome of thrombolytic ineligible patients: Results of the multicenter TIMI 9 Registry (abstr). J Am Coll Cardiol 1995; (special issue): 231A–232A
  • 40. The GUSTO Investigators : An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673–682 [DOI] [PubMed] [Google Scholar]
  • 41. TIMI Study Group : Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. N Engl J Med 1989; 320: 618–627 [DOI] [PubMed] [Google Scholar]
  • 42. Dracup K, Alonzo AA, Atkins JM, Bennett NM, Braslow A, Clark LT, Eisenberg M, Ferdinand KC, Frye R, Green L, Hill MN, Kennedy JW, Kline Rogers E, Moser DK, Ornato JP, Pitt B, Scott JD, Selker HP, Silva SJ, Thies W, Weaver WD, Wenger NK, White SK: Working Group on Educational Strategies to Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction: The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: Recommendations from the National Heart Attack Alert Program. Ann Intern Med 1997; 126: 645–651 [DOI] [PubMed] [Google Scholar]
  • 43. Turi AG, Stone PH, Muller JE, Parker C, Rude RE, Raabe DE, Jaffe AS, Hartwell TD, Robertson TL, Braunwald E: Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. Am J Cardiol 1986; 58: 203–209 [DOI] [PubMed] [Google Scholar]
  • 44. Meischke H, Eisenberg MS, Larsen MP: Prehospital delay interval for patients who use emergency medical services: The effect of heart‐related medical conditions and demographic variables. Ann Emerg Med 1993; 22: 1597–1601 [DOI] [PubMed] [Google Scholar]
  • 45. Cunningham MA, Lee TH, Cooke EF, Brand DA, Rouan GW, Weisberg MC, Goldman L: The effect of gender on the probability of myocardial infarction among emergency department patients with acute chest pain: A report from the Multicenter Chest Pain Study Group. J Gen Intern Med 1989; 4: 392–398 [DOI] [PubMed] [Google Scholar]
  • 46. Alonzo AA: The impact of the family and lay others on care‐seeking during life‐threatening episodes of suspected coronary artery disease. Soc Sci Med 1986; 22: 1297–1311 [DOI] [PubMed] [Google Scholar]
  • 47. Yarzebski J, Goldberg RJ, Gore JM, Alpert JS: Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: The Worcester Heart Attack Study. Am Heart J 1994; 128: 255–263 [DOI] [PubMed] [Google Scholar]
  • 48. Maynard C, Althouse R, Olsufka M, Ritchie JL, Davis KB, Kennedy JW: Early versus late hospital arrival for acute myocardial infarction in the Western Washington thrombolytic therapy trials. Am J Cardiol 1989; 63: 1296–1300 [DOI] [PubMed] [Google Scholar]
  • 49. Weaver WD, Litwin PE, Martin JS, Kudenchuk PJ, Maynard C, Eisenberg MS, Ho MT, Cobb KA, Kennedy JW, Wirkus MS: Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol 1991; 18: 657–662 [DOI] [PubMed] [Google Scholar]
  • 50. Clark LT, Bellan SV, Shah AH, Feldman JG: Analysis of prehospital delay among inner‐city patients with myocardial infarction: Implications for therapeutic intervention. J Natl Med Assoc 1992; 84: 931–937 [PMC free article] [PubMed] [Google Scholar]
  • 51. Cooper RS, Simmons B, Castaner A, Prasad R, Franklin C, Ferlinz J: Survival rates and prehospital delay during myocardial infarction among black persons. Am J Cardiol 1986; 65: 1411–1415 [DOI] [PubMed] [Google Scholar]
  • 52. Ghali JK, Cooper RS, Kowatly I, Liao Y: Delay between onset of chest pain and arrival to the coronary care unit among minority and disadvantaged patients. J Natl Med Assoc 1993; 85: 180–184 [PMC free article] [PubMed] [Google Scholar]
  • 53. Gray D, Keating NA, Murdock J, Skene AM, Hampton JR: Impact of hospital thrombolysis policy on out‐of‐hospital response to suspected myocardial infarction. Lancet 1993; 341: 654–657 [DOI] [PubMed] [Google Scholar]
  • 54. Gillum RF, Feinleib M, Margolis JR, Fabsitz RR, Brasch RC: Delay in the prehospital phase of acute myocardial infarction: Lack of influence on incidence of sudden death. Arch Intern Med 1976; 136: 649–654 [PubMed] [Google Scholar]
  • 55. Weilgosz AT, Nolan RP, Earp JA, Biro E, Weilgosz MB: Reasons for patients' delay in response to symptoms of acute myocardial infarction. Can Med Assoc 1988; 139: 853–857 [PMC free article] [PubMed] [Google Scholar]
  • 56. Ho MT, Eisenberg MS, Litwin PE, Schaeffer SM, Damon SK: Delay between onset of chest pain and seeking medical care: The effect of public education. Ann Emerg Med 1989; 18: 727–731 [DOI] [PubMed] [Google Scholar]
  • 57. Gaspoz J‐M, Unger P‐F, Urban P, Chevrolet J‐C, Rutishauser W, Lovis C, Goldman L, Heliot C, Sechaud L, Mischler S, Waldvogel F: Impact of a public campaign on pre‐hospital delay in patients reporting chest pain. Heart 1996; 76: 150–155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Blohm M, Herlitz J, Hartford M, Karlson BW, Risenfors M, Luepker RV, Sjolin M, Holmberg S: Consequences of a media campaign focusing on delay in acute myocardial infarction. Am J Cardiol 1992; 69: 411–413 [DOI] [PubMed] [Google Scholar]
  • 59. Weaver WD, Eisenberg MC, Martin JS, Litwin PE, Shaeffer SM, Ho MT, Kudenchuk P, Hallstrom AP, Cerqueira MD, Copass MK, Kennedy JW, Cobb LA, Ritchie JL: Myocardial Infarction Triage and Intervention Project—Phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol 1990; 15: 925–931 [DOI] [PubMed] [Google Scholar]
  • 60. McIntyre KM: Cardiopulmonary resuscitation and the ultimate coronary care unit. J Am Med Assoc 1980; 244: 510–511 [PubMed] [Google Scholar]
  • 61. Karagounis L, Ipsen SK, Jessop MR, Gilmore KM, Valenti DA, Clawson JJ, Teichman S, Anderson JL: Impact of field‐transmitted electrocardiography on time to in‐hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1990; 66: 786–791 [DOI] [PubMed] [Google Scholar]
  • 62. Aufderheide TP, Hendley GE, Thakur RK, Mateer JR, Stueven HA, Olson DW, Hargarten KM, Laitinen F, Robinson N, Preuss KC, Hoffman RG: The diagnostic impact of prehospital 12‐lead electrocardiography. Ann Emerg Med 1990; 19: 1280–1287 [DOI] [PubMed] [Google Scholar]
  • 63. Kereiakes DJ, Gibler WB, Martin LH, Pieper KS, Anderson LC, and the Cincinnati Heart Project Study Group : Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: A preliminary report from the Cincinnati Heart Project. Am Heart J 1992; 123: 835–840 [DOI] [PubMed] [Google Scholar]
  • 64. Lambrew CT, Weaver WD, Rogers WJ, Bowlby LJ, Rubison RM, French WJ: Hospital protocols and policies that may delay early identification and thrombolytic therapy of acute myocardial infarction. J Thromb Thrombolysis 1996; 3: 301–306 [DOI] [PubMed] [Google Scholar]
  • 65. Canto JG, Rogers WJ, Bowlby LJ, French WJ, Pearce DJ, Weaver WD: The prehospital electrocardiogram in acute myocardial infarction: Is the full potential being realized? J Am Coll Cardiol 1997; 29: 498–505 [DOI] [PubMed] [Google Scholar]
  • 66. Antman EM, Grudzien C, Sacks DB: Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. J Am Med Assoc 1995; 273: 1279–1282 [PubMed] [Google Scholar]
  • 67. Antman EM, Sacks DB, Rifai N, McCabe CH, Cannon CP, Braunwald E: Time to positivity of a rapid bedside assay for cardiac‐specific troponin T predicts prognosis in acute coronary syndromes: A Thrombolysis in Myocardial Infarction (TIMI) 11A Substudy. J Am Coll Cardiol 1998; 31: 326–330 [DOI] [PubMed] [Google Scholar]
  • 68. Cannon CP, Johnson EB, Cermignani M, Scirica BM, Sagarin MJ, Walls RM: Emergency department thrombolysis critical pathway reduces door‐to‐drug times in acute myocardial infarction. Clin Cardiol 1999; 22: 17–22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Rawles J: Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1994; 23: 1–5 [DOI] [PubMed] [Google Scholar]
  • 70. The European Myocardial Infarction Project Group : Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329: 383–389 [DOI] [PubMed] [Google Scholar]
  • 71. Ferguson JJ: Meeting highlights: 47th Annual Scientific Sessions of the American College of Cardiology. Circulation 1998; 97: 2377–2381 [DOI] [PubMed] [Google Scholar]
  • 72. Ohman EM: SPEED. Presented at the 48th Annual Scientific Session of the American College of Cardiology; March 7–10, 1999; New Orleans, La
  • 73. Greenbaum R, Flaherty M, Chan KL, Shanit D: Failure to improve outcome in suspected acute myocardial infarction by pre‐hospital administration of aspirin (abstr). J Am Coll Cardiol 1996; 27 (suppl A): 11A [Google Scholar]
  • 74. Feinmark S, Behar S, Matetsky S, Feinberg M, Hod H: Time dependent effect of treatment with aspirin during thrombolytic therapy in acute myocardial infarction (abstr). J Am Coll Cardiol 1998; 31 (suppl A): 231A 9426045 [Google Scholar]
  • 75. Ellerbeck EF, Jencks SF, Radford MJ, Kresowik TF, Craig AS, Gold JA, Krumholtz HM, Vogel RA: Quality of care for Medicare patients with acute myocardial infarction: A four‐state pilot study from the Cooperative Cardiovascular Project. J Am Med Assoc 1995; 273: 1509–1514 [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES